The bill would direct the National Institutes of Health to expand and coordinate research on triple-negative breast cancer. It would also require public education materials from the Centers for Disease Control and Prevention and information for health care providers from the Health Resources and Services Administration. The information would cover rates of the cancer, elevated risk for minority women, and treatment options.
The bill would make information about triple-negative breast cancer available to the public and health care providers. It does not describe a new screening or treatment program for patients.
The bill authorizes Congress to provide sums considered necessary for these activities for fiscal years 2026 through 2031. It does not specify dollar amounts.
The bill's findings say more research and education are needed because the cancer can grow and spread quickly, minority women face elevated risk, and current data are limited.
No publicly available information.